Zenobia D’Costa
University of California, Los Angeles(US)Olive View-UCLA Medical Center(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Peptidase Inhibition and Analysis, Cancer Research and Treatments, Ubiquitin and proteasome pathways, Caveolin-1 and cellular processes
Most-Cited Works
- → PD ‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy(2016)223 cited
- → The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma(2015)112 cited
- → Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma(2016)85 cited
- → T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells(2010)73 cited
- → Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer(2017)64 cited
- → TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells(2019)58 cited
- → BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers(2013)53 cited
- → TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes(2021)46 cited
- → TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.(2014)44 cited
- → S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability(2014)32 cited